Clinical Trial Update: Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and posting of results from a drug–drug interaction study testing lemborexant as an adjunct to buprenorphine/n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)
• Lemborexant (lemborexant)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Drug Interaction, Analgesics | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-13